AU2001258598A1 - Use of metal compounds to treat gastrointestinal infections - Google Patents

Use of metal compounds to treat gastrointestinal infections

Info

Publication number
AU2001258598A1
AU2001258598A1 AU2001258598A AU5859801A AU2001258598A1 AU 2001258598 A1 AU2001258598 A1 AU 2001258598A1 AU 2001258598 A AU2001258598 A AU 2001258598A AU 5859801 A AU5859801 A AU 5859801A AU 2001258598 A1 AU2001258598 A1 AU 2001258598A1
Authority
AU
Australia
Prior art keywords
metal compounds
gastrointestinal infections
treat gastrointestinal
treat
infections
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001258598A
Inventor
Sylvaine Francoise Aline Bruggraber
Jonathan Joseph Powell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfylori Ltd
Original Assignee
Pfylori Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfylori Ltd filed Critical Pfylori Ltd
Publication of AU2001258598A1 publication Critical patent/AU2001258598A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001258598A 2000-05-24 2001-05-24 Use of metal compounds to treat gastrointestinal infections Abandoned AU2001258598A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0012487.5A GB0012487D0 (en) 2000-05-24 2000-05-24 Use of metal compounds to treat gastrointestinal infections
GB0012487 2000-05-24
PCT/GB2001/002277 WO2001089534A1 (en) 2000-05-24 2001-05-24 Use of metal compounds to treat gastrointestinal infections

Publications (1)

Publication Number Publication Date
AU2001258598A1 true AU2001258598A1 (en) 2001-12-03

Family

ID=9892180

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001258598A Abandoned AU2001258598A1 (en) 2000-05-24 2001-05-24 Use of metal compounds to treat gastrointestinal infections

Country Status (4)

Country Link
US (1) US7811609B2 (en)
AU (1) AU2001258598A1 (en)
GB (2) GB0012487D0 (en)
WO (1) WO2001089534A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003904192A0 (en) * 2003-08-11 2003-08-21 Adelaide Research and Innovaiton Pty Ltd Method for inhibiting bacterial colonisation
GB0808835D0 (en) 2008-05-15 2008-06-18 Vitra Pharmaceuticals Ltd Therapeutic compositions
WO2010004653A1 (en) * 2008-07-11 2010-01-14 アンスラックス スポアーズ キラー コーポレーション リミテッド Eradicating agent and eradication method for helicobacter pylori
BR112013018534B1 (en) 2011-01-20 2021-04-06 Board Of Regents, The University Of Texas System CONTRAST AGENT, ITS PREPARATION METHODS, AND COMBINATION PRODUCT
FI20115377A (en) * 2011-04-18 2012-10-19 Biohit Oyj Medical products for use in conditions related to microbial infections of upper respiratory and digestive organs
CN115448376B (en) * 2022-09-05 2024-04-19 中国科学院深圳先进技术研究院 Preparation method of cobalt-based nano sheet, cobalt-based nano sheet and application

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB756825A (en) * 1953-11-03 1956-09-12 Fort Dodge Lab Inc Therapeutic preparations effective against mastitis
US4326523A (en) * 1980-08-25 1982-04-27 International Minerals & Chemical Corp. Method of supplying micronutrients to animals
US5304540A (en) * 1988-06-22 1994-04-19 Applied Microbiology, Inc. Pharmaceutical bacteriocin compositions and methods for using the same
FR2740342B1 (en) * 1995-10-26 1997-12-19 Oreal USE OF LANTHANIDE, MANGANESE, LITHIUM, TIN, ZINC OR YTTRIUM SALT, COBALT, BARIUM, STRONTIUM IN PHARMACEUTICAL COMPOSITIONS
SE507682C2 (en) * 1996-03-29 1998-07-06 Marcin Krotkiewski Pharmaceutical preparation for the treatment of gastritis, reflux oesophagitis, duodenitis, dyspepsia and peptic ulcer disease containing a mixture of ammonium bismuth citrate and an alginate
HU225329B1 (en) 1996-09-12 2006-09-28 Richter Gedeon Vegyeszet Use of zinc or cobalt hyaluronate associate for the manufacture of pharmaceutical compositions of antimicrobial activity
GB9621273D0 (en) 1996-10-11 1996-11-27 Cortecs Ltd Therapeutic method
CN1262281C (en) * 1999-03-17 2006-07-05 森永制果株式会社 Drugs, foods, drinks and feeds containing cocoa component

Also Published As

Publication number Publication date
GB2379388A (en) 2003-03-12
GB0229868D0 (en) 2003-01-29
GB2379388B (en) 2004-10-06
US7811609B2 (en) 2010-10-12
WO2001089534A1 (en) 2001-11-29
US20030180381A1 (en) 2003-09-25
GB0012487D0 (en) 2000-07-12

Similar Documents

Publication Publication Date Title
AU2001266068A1 (en) Treatment of mineral substrates
AU2001284646A1 (en) Quinuclidine-substituted heteroaryl moieties for treatment of disease
IL158643A0 (en) Use of hmg fragments as anti-inflammatory agents
AU2001272849A1 (en) Composition for the treatment of osteoarthritis
AU2002359659A1 (en) Cross reference to related application
AU2001269704A1 (en) Oxazinoquinolones useful for the treatment of viral infections
AU2002354951A1 (en) Use of copper chelators to inhibit the inactivation of protein c
AU2002364964A8 (en) Galliumcomplexes of 3-hydroxy-4-pyrones to treat mycobacterial infections
AU2001285325A1 (en) Use of threo-methylphenidate compounds to enhance memory
AU2001237992A1 (en) Purification of oligonucleotides
AU2002231206A1 (en) Treatment of depression
AU2002322481A1 (en) Use of r-nsaid compounds for anti-hiv treatment
AU2002217071A1 (en) Novel use of polyhydroxy compounds
AU2001258598A1 (en) Use of metal compounds to treat gastrointestinal infections
AU2003301012A1 (en) Use of beta-defensins for treating hiv infections
AU2001245414A1 (en) Treatment of allergies
AU2002214868A1 (en) Therapeutic oligonucleotides of reduced toxicity
AU2002242096A1 (en) Novel compounds and methods for inhibiting/treating hiv infections and aids related symptoms
EP1215193A3 (en) Production of 2-hydrocarbyl-2-adamantyl acrylate compounds
GB9919035D0 (en) Use of metal compounds to treat gastrointestinal infections
AU5812601A (en) Treatment of il-10 deficiencies
AU2001255378A1 (en) Inhibition of transmission of tick-borne infections
AU2002221882A1 (en) Use of 3-hydroxyl-3-methylglutaryl-coenzyme-a-reductase inhibitors
AU2002341485A1 (en) Treatment of polyaluminium compounds
AU2001258330A1 (en) New uses of imidazolylmethyl-pyridines